Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB08933> ?p ?o ?g. }
Showing items 1 to 16 of
16
with 100 items per page.
- drugbank:DB08933 type drugbank_vocabulary:Drug assertion.
- drugbank:DB08933 label "LULICONAZOLE [drugbank:DB08933]" assertion.
- drugbank:DB08933 seeAlso DB08933 assertion.
- drugbank:DB08933 seeAlso luliconazole.html assertion.
- drugbank:DB08933 seeAlso luzu-drug.htm assertion.
- drugbank:DB08933 identifier "drugbank:DB08933" assertion.
- drugbank:DB08933 description "Luliconazole was approved by the FDA (USA) in November 2013 and is marketed under the brand name Luzu. It is a topical antifungal agent that acts by unknown mechanisms but is postulated to involve altering the synthesis of fungi cell membranes. Luliconazole is also approved in Japan." assertion.
- drugbank:DB08933 title "LULICONAZOLE" assertion.
- drugbank:DB08933 bio2rdf_vocabulary:identifier "DB08933" assertion.
- drugbank:DB08933 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB08933 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB08933" assertion.
- drugbank:DB08933 bio2rdf_vocabulary:x-identifiers.org DB08933 assertion.
- drugbank:DB08933 drugbank_vocabulary:drugbank-id "DB08933" assertion.
- drugbank:DB08933 drugbank_vocabulary:x-cas cas:187164-19-8 assertion.
- drugbank:DB08933 drugbank_vocabulary:x-kegg kegg:D01980 assertion.
- drugbank:DB08933 drugbank_vocabulary:x-ndc ndc:99207-850-30 assertion.